Inhalerx Ltd
ASX:IRX
Balance Sheet
Balance Sheet Decomposition
Inhalerx Ltd
Inhalerx Ltd
Balance Sheet
Inhalerx Ltd
| Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
8
|
5
|
2
|
0
|
2
|
3
|
2
|
1
|
0
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
8
|
5
|
2
|
0
|
2
|
3
|
2
|
1
|
0
|
|
| Total Receivables |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Accounts Receivables |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
8
|
5
|
3
|
1
|
2
|
3
|
2
|
2
|
1
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
9
N/A
|
5
-41%
|
3
-39%
|
1
-80%
|
2
+205%
|
3
+54%
|
2
-23%
|
2
-30%
|
1
-55%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
1
|
1
|
0
|
0
|
1
|
0
|
0
|
1
|
1
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
1
N/A
|
1
-54%
|
0
-87%
|
0
+267%
|
1
+105%
|
0
-56%
|
0
+40%
|
1
+157%
|
0
-51%
|
|
| Equity | ||||||||||
| Common Stock |
8
|
8
|
8
|
8
|
10
|
13
|
14
|
14
|
15
|
|
| Retained Earnings |
1
|
3
|
5
|
8
|
9
|
10
|
12
|
13
|
14
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
7
N/A
|
5
-38%
|
3
-33%
|
0
-89%
|
1
+289%
|
3
+102%
|
2
-29%
|
1
-65%
|
0
-60%
|
|
| Total Liabilities & Equity |
9
N/A
|
5
-41%
|
3
-39%
|
1
-80%
|
2
+205%
|
3
+54%
|
2
-23%
|
2
-30%
|
1
-55%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
77
|
77
|
80
|
80
|
135
|
168
|
189
|
191
|
215
|
|